It's a quarterly newsletter update. Of course it's going to be focused on Azer-cel, the company has released very promising results this quarter. Vaxinia and onCARlytics updates are still to come, there is no new released data to discuss or present. The only thing the company can say in regards to the CF33 suite is "we will release data soon" which the market is well aware of. The latest Vaxinia data is from November 2023 so there's literally no update (currently) to discuss.
It may sound obvious but when the new CF33 data is released, expected in Q2 2025, the company will have plenty to talk about.
My simple opinion, DYOR. GLTAH.
Shornba
IMU Price at posting:
3.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)